CI
NVO

Capital International’s Novo Nordisk NVO Stock Holding History

Capital International’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-32,458
Closed -$2.24M – 150
2025
Q2 		$2.24M Buy
32,458
+453
+1% +$30.8K 0.09% 133
2025
Q1 		$2.22M Buy
32,005
+3,477
+12% +$287K 0.1% 131
2024
Q4 		$2.45M Buy
28,528
+3,856
+16% +$417K 0.1% 131
2024
Q3 		$2.94M Buy
24,672
+709
+3% +$94.6K 0.13% 124
2024
Q2 		$3.42M Sell
23,963
-4,158
-15% -$551K 0.16% 119
2024
Q1 		$3.61M Hold
28,121
– – 0.17% 115
2023
Q4 		$2.91M Sell
28,121
-7,617
-21% -$753K 0.15% 126
2023
Q3 		$3.25M Sell
35,738
-10,456
-23% -$921K 0.19% 116
2023
Q2 		$3.74M Sell
46,194
-4,572
-9% -$373K 0.21% 112
2023
Q1 		$4.04M Buy
50,766
+9,934
+24% +$704K 0.24% 113
2022
Q4 		$2.76M Buy
40,832
+7,728
+23% +$453K 0.19% 124
2022
Q3 		$1.65M Buy
33,104
+14,850
+81% +$796K 0.11% 141
2022
Q2 		$1.02M Buy
+18,254
New +$1.01M 0.08% 144

Other funds holding NVO

Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Capital International's NVO Position: Q3 2025 in Review

Capital International sold out of Novo Nordisk (NVO) in Q3 2025, closing a stake of 32,458 shares — an estimated $2.24M sold.

Capital International first reported a position in NVO in Q2 2022 and held it in 13 quarters. The position peaked at $4.04M in Q1 2023. 1,395 funds tracked by Wall St. Rank hold NVO as of Q3 2025.

  • Capital International reported no remaining Novo Nordisk position as of Q3 2025 after selling out during the quarter.
  • Capital International sold 32,458 Novo Nordisk shares in Q3 2025, an estimated $2.24M.
  • Capital International first reported a position in Novo Nordisk in Q2 2022 and held it in 13 quarters.
  • Capital International's Novo Nordisk position peaked at $4.04M in Q1 2023.
  • 1,395 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2025.

Based on Capital International's 13F filing for Q3 2025, filed 13 Nov 2025.